February 2026 was the month the money started moving again. The full-year earnings from the public quantum names landed with a distinctly commercial flavor — D-Wave's report in particular read like a company that has finally found its market — while private capital began circling the sector's most promising private names, most visibly PASQAL. Yet the same month brought a quieter, more sobering data point: institutional investors trimmed their stakes in several listed quantum companies during the fourth quarter. February, in other words, was a month of two moods — enthusiasm at the edges, caution at the core.
The month in review
The defining event was D-Wave's full-year 2025 results, reported in late February. The headline was a roughly 180 percent jump in annual revenue, with the company pointing to accelerating bookings and improving gross margins. For a sector that has spent years defending valuations on promise alone, that is the shape of a story investors actually want to hear: revenue compounding, bookings ahead of revenue, and a path — however long — toward something like operating leverage. The caveat is the same one that has applied to every quantum earnings report to date: the base is small, the burn is real, and one strong year does not a business model make. But as far as quarterly installments go, this one was the strongest the sector has produced.
The month's second theme was the quiet warming of the private markets. Bloomberg reported that PASQAL was in discussions to raise €200 million at a valuation above $1 billion — a figure that, if realized, would make the French neutral-atom firm one of the best-capitalized private quantum companies in Europe and set up the sector's next big liquidity event. The report mattered as much for what it signaled as for its specifics: after two years in which private quantum funding was cautious and concentrated, the checkbooks are opening again, and the firms with credible hardware roadmaps are the ones being courted.
The industrial logic of January carried straight through. Tower Semiconductor and Xanadu announced a partnership aimed at bringing quantum chip manufacturing into a commercial foundry — precisely the kind of move that turns "we can fabricate it" from a claim into a process. IBM Ventures disclosed new investments in quantum software startups SQK and QodeX, a small but telling sign that the largest incumbent in the field is placing bets across the software stack rather than only inside its own walls. And AQT and Scaleway launched a European quantum cloud access partnership, the kind of sovereignty-flavored infrastructure play that has become a recurring motif from Brussels outward.
What moved the sector
D-Wave's report deserves a closer look, because it is the clearest evidence yet that annealing systems have a commercial constituency. The company's bookings narrative — customers signing up for real workloads, not just pilots — is the metric that separates it from peers whose revenue is still measured in proof-of-concept grants. The skeptical read is equally available: annealing is a narrower computational niche than gate-model quantum computing, and a strong year in a niche is not the same as broad market validation. Both readings are true, and the market's job in 2026 is to figure out which one dominates over time.
The foundry story also advanced on multiple fronts. The Tower–Xanadu partnership is the most concrete example of a photonic player outsourcing manufacturing to a commercial fab, which is the only credible path to the volumes quantum networking and photonic computing will eventually need. SkyWater's fiscal results, reported the same week, provided a window into the economics of the foundry side of the equation — the infrastructure companies are scaling up even as their quantum-specific revenue remains modest, a reminder that the supply chain is being built ahead of demand, and that investors in the ecosystem are paying for optionality.
Two items point in the direction the sector is heading rather than where it has been. Xanadu and Lockheed Martin announced a quantum machine-learning initiative, an early signal that defense and aerospace buyers are beginning to fund applied work on quantum processors rather than just monitoring the field. And the UK's Defence Science and Technology Laboratory reported progress on next-generation atomic clocks — a quiet but strategically significant reminder that quantum sensing and timing, not just computing, are where near-term government money is concentrating. Quantum clocks are deployable today in ways that fault-tolerant computers are not, and the defense establishment knows it.
The counterweight to all of this landed in the same week as D-Wave's earnings: reporting that institutional investors trimmed their ownership stakes in three publicly traded quantum computing companies during the fourth quarter. The trimming was modest and could reflect any number of portfolio mechanics — rebalancing, tax positioning, fund outflows — but the timing is worth noting. It came after a period in which quantum stocks had run hard on narrative, and before the fundamentals had fully caught up. The professional money was, in effect, taking some risk off the table while the retail narrative burned bright. That is not a sell signal for the sector; it is a reminder that the sector's valuation debate is far from settled.
Beneath the capital markets headlines, the sector's operational layer kept compounding. Welinq and PASQAL deepened their quantum networking collaboration, an early piece of the interconnect infrastructure that distributed quantum computing will eventually require. Clemson University moved to position South Carolina in the workforce race, adding to the state-level competition that has become a defining feature of the American quantum map. None of these made headlines; all of them are the kind of groundwork that determines which ecosystems actually deliver. The uncomfortable truth of the month is that the capital markets moved faster than the operating metrics, and the institutional trimming was the market's way of acknowledging it.
Upcoming catalysts to watch
March is shaping up as the sector's busiest month of the young year on the capital markets front. PASQAL's reported €200 million raise is one thread; the larger one is the cluster of public-listing moves that have been building in the background. Xanadu's business combination with Crane Harbor was headed for a shareholder vote in mid-March, with the company targeting a raise on the order of $300 million — a test of whether public investors will fund a pure-play photonic quantum company at scale. Horizon Quantum's SPAC deal, expected to close around the same time and raise on the order of $120 million, will add a Singapore-based software-first name to the public roster. If both price and trade well, the sector gets a second wind; if they stumble, the pure-play basket reprices.
Also worth watching: the first-quarter earnings cycle, which will test whether the revenue momentum visible in D-Wave's full-year report extends across the group; the formalization of U.S. CHIPS program decisions on quantum fabrication, which will name the domestic suppliers of record; and the continuing flow of post-quantum cryptography mandates, where China's reported push for national PQC standards within three years is the latest evidence that the security side of the sector has its own, faster clock. Investors should also keep an eye on any movement in the EU's industrial policy — early drafts of the bloc's competitiveness plans reportedly dropped quantum from some priority lists, a reminder that European policy support is not guaranteed to keep rising.
Predictions
Three hedged calls. First, the spring listing wave will be the sector's most important valuation event of the first half — the Xanadu and Horizon deals, plus whatever follows PASQAL's raise, will do more to set the pure-play pricing floor than any single earnings report, and the outcomes are genuinely two-sided. Second, the institutional trimming that showed up in Q4 filings will continue quietly through the first half of 2026 even as retail interest stays elevated; expect the share registers of the smaller pure-plays to look meaningfully different by summer, with professional ownership down and the float increasingly retail. Third, the revenue dispersion between the leaders and the rest will widen: companies with real bookings — D-Wave, IonQ — will keep compounding, while names whose revenue is still dominated by grants and partnerships will see their multiples compress as the market demands evidence.
The bottom line
February's earnings season delivered the first genuinely commercial report card the quantum sector has produced, and the private market responded by circling the strongest names with fresh capital. But the same month's institutional trimming is a useful corrective: the professionals are treating this as a maturing sector whose winners will be proven by revenue, not by narrative. The spring will tell us which reading the market trusts, one listing and one earnings call at a time.